This inventor holds 2 USPTO granted patents. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 1998-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-1999
Title: Craig D. Furman: Innovator in Immunogenic Peptides
Introduction
Craig D. Furman is a notable inventor based in Nashua, NH (US). He has made significant contributions to the field of immunology, particularly through his work on immunogenic peptides and antibodies. With a total of 2 patents, Furman's innovations are paving the way for advancements in treatment and prophylaxis.
Latest Patents
Furman's latest patents focus on immunogenic peptides and antibodies related to the CD4 receptor. These patents disclose immunogenic peptides containing amino acid residues that define a binding site to the CD4 receptor. Additionally, antibodies to these peptides are also disclosed. The patents describe methods for reducing the ability of a gp120 env protein to bind to CD4, along with methods of treatment and prophylaxis using these antibodies and peptides.
Career Highlights
Craig D. Furman is associated with the Dana-Farber Cancer Institute Inc., where he continues to contribute to groundbreaking research in immunology. His work has implications for the development of therapies targeting various diseases.
Collaborations
Furman has collaborated with esteemed colleagues such as Joseph G. Sodroski and William A. Haseltine, further enhancing the impact of his research in the scientific community.
Conclusion
Craig D. Furman's innovative work in immunogenic peptides and antibodies showcases his commitment to advancing medical science. His contributions are vital for the development of new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile